Clinical Commissioning Policy: Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex

Document first published:
Page updated:
Publication type:
This document describes the evidence that has been considered by NHS England in formulating a proposal to routinely commission everolimus for the specific group of patients with SEGAs which are not amenable to surgery.